Caris Life Sciences (CAI) Change in Cash (2024 - 2026)

Caris Life Sciences' Change in Cash history runs 3 years deep, the most recent figure standing at $23.3 million for Q1 2026.

• In Q1 2026, Change in Cash rose 171.32% year-over-year to $23.3 million; the TTM figure through Mar 2026 stood at $788.1 million (changed N/A YoY), while the FY2025 annual figure was $732.0 million, up 9026.22% from the prior year.
• Change in Cash was $23.3 million for Q1 2026 at Caris Life Sciences, down from $43.1 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $687.4 million in Q2 2025 to a low of -$71.2 million in Q3 2024.
• Historically, Change in Cash has averaged $91.9 million across 3 years, with a median of $23.3 million in 2026.
• Biggest YoY gain for Change in Cash was 205.06% in 2025; the steepest drop was 148.18% in 2025.
• A 3-year view of Change in Cash shows it stood at -$41.0 million in 2024, then jumped by 205.06% to $43.1 million in 2025, then slumped by 45.78% to $23.3 million in 2026.
• The last three Change in Cash figures came in at $23.3 million (Q1 2026), $43.1 million (Q4 2025), and $34.3 million (Q3 2025), per Business Quant data.